A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion
- PMID: 22889699
- DOI: 10.3727/096368912X653246
A novel strategy to enhance mesenchymal stem cell migration capacity and promote tissue repair in an injury specific fashion
Abstract
Mesenchymal stem cells (MSCs) of bone marrow origin appear to be an attractive candidate for cell-based therapies. However, the major barrier to the effective implementation of MSC-based therapies is the lack of specific homing of exogenously infused cells and overall the inability to drive them to the diseased or damaged tissue. In order to circumvent these limitations, we developed a preconditioning strategy to optimize MSC migration efficiency and potentiate their beneficial effect at the site of injury. Initially, we screened different molecules by using an in vitro injury-migration setting, and subsequently, we evaluated the effectiveness of the different strategies in mice with acute kidney injury (AKI). Our results showed that preconditioning of MSCs with IGF-1 before infusion improved cell migration capacity and restored normal renal function after AKI. The present study demonstrates that promoting migration of MSCs could increase their therapeutic potential and indicates a new therapeutic paradigm for organ repair.
Similar articles
-
Migration of CXCR4 gene-modified bone marrow-derived mesenchymal stem cells to the acute injured kidney.J Cell Biochem. 2013 Dec;114(12):2677-89. doi: 10.1002/jcb.24615. J Cell Biochem. 2013. PMID: 23794207
-
Erythropoietin promotes the repair effect of acute kidney injury by bone-marrow mesenchymal stem cells transplantation.Exp Biol Med (Maywood). 2013 Jun;238(6):678-86. doi: 10.1177/1535370213489486. Exp Biol Med (Maywood). 2013. PMID: 23918879
-
Overexpression of the mesenchymal stem cell Cxcr4 gene in irradiated mice increases the homing capacity of these cells.Cell Biochem Biophys. 2013;67(3):1181-91. doi: 10.1007/s12013-013-9632-6. Cell Biochem Biophys. 2013. PMID: 23712865
-
Mesenchymal stem cells in acute kidney injury.Annu Rev Med. 2008;59:311-25. doi: 10.1146/annurev.med.59.061506.154239. Annu Rev Med. 2008. PMID: 17914926 Review.
-
Therapeutic action of bone marrow-derived stem cells against acute kidney injury.Life Sci. 2014 Oct 12;115(1-2):1-7. doi: 10.1016/j.lfs.2014.08.025. Epub 2014 Sep 16. Life Sci. 2014. PMID: 25219881 Review.
Cited by
-
Dexamethasone and azathioprine promote cytoskeletal changes and affect mesenchymal stem cell migratory behavior.PLoS One. 2015 Mar 10;10(3):e0120538. doi: 10.1371/journal.pone.0120538. eCollection 2015. PLoS One. 2015. PMID: 25756665 Free PMC article.
-
Single-cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneity.Clin Transl Med. 2021 Dec;11(12):e650. doi: 10.1002/ctm2.650. Clin Transl Med. 2021. PMID: 34965030 Free PMC article.
-
Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis.Biomed Res Int. 2013;2013:561098. doi: 10.1155/2013/561098. Epub 2013 Dec 5. Biomed Res Int. 2013. PMID: 24381939 Free PMC article. Review.
-
Administration of BMSCs with muscone in rats with gentamicin-induced AKI improves their therapeutic efficacy.PLoS One. 2014 May 13;9(5):e97123. doi: 10.1371/journal.pone.0097123. eCollection 2014. PLoS One. 2014. PMID: 24824427 Free PMC article.
-
Osteogenesis of bone marrow mesenchymal stem cell in hyperglycemia.Front Endocrinol (Lausanne). 2023 Jun 21;14:1150068. doi: 10.3389/fendo.2023.1150068. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37415664 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
